CR9845A - Forma farmaceutica que contiene metocarbamol, meloxicam y betametasona - Google Patents

Forma farmaceutica que contiene metocarbamol, meloxicam y betametasona

Info

Publication number
CR9845A
CR9845A CR9845A CR9845A CR9845A CR 9845 A CR9845 A CR 9845A CR 9845 A CR9845 A CR 9845A CR 9845 A CR9845 A CR 9845A CR 9845 A CR9845 A CR 9845A
Authority
CR
Costa Rica
Prior art keywords
metocarbamol
betametasone
meloxicam
form containing
pharmaceutical form
Prior art date
Application number
CR9845A
Other languages
English (en)
Inventor
Armenta Maria Elena Garcia
Ochoa Victor Guillermo Alvarez
Murillo Josefina Santos
Barba Sandra Cecilia Flores
Alvarez Aracelly Alvarez
Original Assignee
World Trade Imp Export Wtie A G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by World Trade Imp Export Wtie A G filed Critical World Trade Imp Export Wtie A G
Publication of CR9845A publication Critical patent/CR9845A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invencion esta relacionada con la industria farmaceutica en general y con la industria farmaceutica preparadora de medicamentos para el tratamiento de casos agudos y exacerbaciones de pacientes con artritis reumatoide, espondilitis anquilosante, osteoartritis, alivio del dolor y la inflamacion de artritis gotosa aguda, bursitis aguda y subaguda, tendinitis, sinovitis.
CR9845A 2005-09-29 2008-03-28 Forma farmaceutica que contiene metocarbamol, meloxicam y betametasona CR9845A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MXPA05010506A MXPA05010506A (es) 2005-09-29 2005-09-29 Forma farmaceutica para el tratamiento de casos agudos y exacerbaciones de pacientes con artritis reumatoide, y transtornos agudos relacionados.

Publications (1)

Publication Number Publication Date
CR9845A true CR9845A (es) 2008-06-19

Family

ID=37900029

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9845A CR9845A (es) 2005-09-29 2008-03-28 Forma farmaceutica que contiene metocarbamol, meloxicam y betametasona

Country Status (6)

Country Link
EP (1) EP1941910A1 (es)
BR (1) BRPI0616686A2 (es)
CR (1) CR9845A (es)
EC (1) ECSP088327A (es)
MX (1) MXPA05010506A (es)
WO (1) WO2007037667A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103405335A (zh) * 2013-08-02 2013-11-27 山东威高集团医用高分子制品股份有限公司 一种表面修饰的胶塞及其制备方法
CN111316788A (zh) * 2020-02-27 2020-06-23 清上(苏州)环境科技有限公司 一种水生植物人工种子及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0205492A1 (en) * 1984-12-26 1986-12-30 SUNSHINE, Abraham Analgesic, anti-inflammatory and skeletal muscle relaxant compositions
WO1997020551A1 (en) * 1995-12-05 1997-06-12 Adcock Ingram Limited Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic

Also Published As

Publication number Publication date
EP1941910A1 (en) 2008-07-09
WO2007037667A1 (es) 2007-04-05
MXPA05010506A (es) 2007-03-28
BRPI0616686A2 (pt) 2011-06-28
ECSP088327A (es) 2008-05-30

Similar Documents

Publication Publication Date Title
UA120948C2 (uk) Заміщені індазоли, способи їх одержання, фармацевтичні препарати, які їх містять, та їх застосування для одержання лікарських засобів
CO2019005287A2 (es) Compuestos de 7-feniletilamino-4h-pirimido[4,5-d][1,3]-oxazin-2-ona como inhibidores de idh1 e idh2 mutantes
CL2007002375A1 (es) Compuestos derivados de heteroarilo, inhibidores de citocina; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del dolor, cancer, inflamacion, artritis, psoriasis, diabetes,
ATE507863T1 (de) Medizinisches abgabesystem mit einem arretierungsring mit l-förmigen nuten
BR112012005970A2 (pt) moduladores tricíclicos de proteína quinase
BR112018010671A8 (pt) dispositivos e métodos de distribuição de fármaco com mudança de forma
CL2007003389A1 (es) Formas cristalinas de sales de acido zoledronico; composicion farmaceutica; y uso en el tratamiento del cancer.
CL2016000117A1 (es) Autotaxina inhibidores comprende un anillo heteroaromático-bencilamina ciclo basico
CL2014002237A1 (es) Anticuerpo anti-sez6; dicho anticuerpo conjugado con un fármaco; medicamento que los comprende; y uso para el tratamiento del cáncer.
BR112012005957A2 (pt) compostos tricíclicos e usos farmacêuticos dos mesmos
CL2013002898A1 (es) Compuestos derivados de benceno sustituido con arilo o heteroarilo; composicion farmaceutica que los comprende y uso en el tratamiento del cancer.
ECSP088325A (es) Forma farmacéutica que contiene metocarbamol, meloxicam y betametasona
UY31053A1 (es) Derivados heterociclicos, procesos para su produccion, medicamentos que comprende estos compuestos y su uso
BR112015021495A2 (pt) fabricação contínua integrada de substâncias de droga de proteína terapêutica
EP2629342A4 (en) UNSATURATED POLYESTER RESIN COMPOSITION FOR USE IN LED REFLECTOR AND LIGHT REFLECTOR AND LED LIGHT WITH SAID
CR20120035A (es) Terapia combinatoria de un anticuerpo anti-cd20 afucosilado con fludarabina y/o mitoxantrona
PE20120003A1 (es) Hidrocloruro de n-{(1s)-2-amino-1-[(3-fluorofenil)metil)etil}-5-cloro-4-(4-cloro-1-metil-1h-pirazol-5-il)-2-tiofenocarboxamida cristalino
CL2009001785A1 (es) Metodo para preparar directamente 1-metilciciclopropeno in situ sin producir el subproducto volatil fluortrimetilsilano, el cual consiste en hacer reaccionar un precursor de 1-metilciciclopropeno con tetrabutilamoniaco.
CY1122198T1 (el) Ιατρικο προϊον και θεραπεια
EP3436595C0 (en) MICROBIAL CELLS OPTIMIZED FOR THE PRODUCTION OF MELATONIN AND OTHER COMPOUNDS
EA201692392A1 (ru) Новая лекарственная форма мелоксикама
EA201390616A1 (ru) ЛЕЧЕНИЕ НАРУШЕНИЙ, АССОЦИИРОВАННЫХ С ГЕНОМ MeCP2
CR9845A (es) Forma farmaceutica que contiene metocarbamol, meloxicam y betametasona
MX2019014923A (es) Régimen de dosificación.
UY34178A (es) Dosificación y administración de anticuerpos anti-erbb3 en combinación con paclitaxel para el tratamiento de cánceres ginecológicos.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)